Raleigh Capital Management Inc. Tekla Life Sciences Investors Transaction History
Raleigh Capital Management Inc.
- $232 Million
- Q2 2024
A detailed history of Raleigh Capital Management Inc. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 104 shares of HQL stock, worth $1,589. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104Holding current value
$1,589% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
76Shares Held
9.04MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$52.4 Million0.82% of portfolio
-
Morgan Stanley New York, NY490KShares$7.49 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA419KShares$6.41 Million0.53% of portfolio
-
Karpus Management, Inc. Pittsford, NY404KShares$6.18 Million0.18% of portfolio
-
Allspring Global Investments Holdings, LLC347KShares$5.3 Million0.01% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...